Thomas Jefferson University
The goal of this clinical trial is to learn whether multiparametric ultrasound (mp-US) can detect clinically significant prostate cancer as effectively as multiparametric MRI (mp-MRI) in adult men undergoing prostate biopsy for suspected prostate cancer. The main questions it aims to answer are: Does mp-US-guided targeted biopsy detect clinically significant prostate cancer at a rate that is not inferior to mp-MRI-guided targeted biopsy? Can mp-US imaging collected at the time of biopsy be used to identify suspicious prostate lesions for targeted sampling? Researchers will compare mp-US-guided targeted biopsy plus systematic biopsy with mp-MRI-guided targeted biopsy plus systematic biopsy to see if mp-US achieves a similar detection rate for clinically significant prostate cancer. Participants will: Undergo mp-MRI within 30 days before prostate biopsy. Receive mp-US imaging at the time of biopsy. Undergo up to three mp-US-targeted biopsy cores of suspicious areas. Undergo up to three mp-MRI-targeted biopsy cores of suspicious areas. Receive a standard systematic prostate biopsy consisting of 12 biopsy cores.
This protocol describes the final part of a three part NIH funded study to develop and validate multiparametric ultrasound (mp-US) for the diagnosis of prostate cancer. The first part of the project developed the hardware to perform ultrasound elastography, contrast ultrasound dispersion imaging (CUDI) and contrast ultrasound subharmonic imaging (SHI) on a US system capable of using these techniques to guide a transrectal fusion biopsy of the prostate. The second part of the project is collecting mp-US data on 50 patients immediately prior to radical prostatectomy, and correlating the imaging…
Inclusion Criteria: Individuals must meet all of the following inclusion criteria in order to be eligible to participate in the study: * Subject must be scheduled for a prostate biopsy, based on an elevated PSA (\>3.0ng/ml per most recent NCCN guidelines, elevated PSA velocity (\>0.75ng/ml/year), or abnormal digital rectal examination. * Subject must be able and willing to give written informed consent for a contrast enhanced ultrasound study of the prostate including the additional study biopsies. * Subject must be a male at least 18 years of age when informed consent is obtained. Exclusio…
Undergo mp-MRI
Given IV
Undergo transrectal mp-US
Undergo prostate biopsies